![conference banner](/images/conference-banner.jpeg)
Abstract
Background: Considering that inflammation is involved in many degenerative conditions, some derivatives of tolfenamic acid, naproxen and indomethacin were synthesised and evaluated biologically. They were found to possess increased anti-inflammatory activity, being more potent than the parent drugs.
Method: Thus, compound 4, the ester of naproxen with di-tert-butyl-4-(hydroxymethyl)phenol, caused about 80% reduction of carrageenan-induced rat paw oedema, much higher than that of the starting drug. The antioxidant structure containing compounds 1-4 could inhibit soybean lipoxygenase, as well as rat microsomal membrane lipid peroxidation, both effects attributed to the presence of SH or phenolic groups. The effect of compound 1, the amide of tolfenamic acid with L-cysteine ethyl ester, on paracetamol-induced oxidative liver injury and on brain oxidative stress caused by ischemia– reperfusion was examined. Results: It was found that 1 could protect rat liver from glutathione depletion, being comparable to Nacetylcysteine, the classical antidote against paracetamol overdose, and restore hepatic function, as judged by the levels of hepatic enzymes in plasma and the microscopic examination of multiple liver slices. After cerebral ischemia, 1 reduced caspase-3 by 60% and significantly decreased the number of apoptotic cells, especially in hippocampus and cerebellum.Keywords: Anti-inflammatory activity, brain ischemia-reperfusion, liver injury, indomethacin, naproxen, tolfenamic acid.
Letters in Drug Design & Discovery
Title:Improved Anti-inflammatory Activity and Potential Cytoprotective Properties of Tolfenamic Acid, Naproxen and Indomethacin Derivatives
Volume: 14 Issue: 4
Author(s): Panagiotis Theodosis-Nobelos, Theodora C. Politou, Chrysoula Athanasekou and Eleni A. Rekka
Affiliation:
Keywords: Anti-inflammatory activity, brain ischemia-reperfusion, liver injury, indomethacin, naproxen, tolfenamic acid.
Abstract: Background: Considering that inflammation is involved in many degenerative conditions, some derivatives of tolfenamic acid, naproxen and indomethacin were synthesised and evaluated biologically. They were found to possess increased anti-inflammatory activity, being more potent than the parent drugs.
Method: Thus, compound 4, the ester of naproxen with di-tert-butyl-4-(hydroxymethyl)phenol, caused about 80% reduction of carrageenan-induced rat paw oedema, much higher than that of the starting drug. The antioxidant structure containing compounds 1-4 could inhibit soybean lipoxygenase, as well as rat microsomal membrane lipid peroxidation, both effects attributed to the presence of SH or phenolic groups. The effect of compound 1, the amide of tolfenamic acid with L-cysteine ethyl ester, on paracetamol-induced oxidative liver injury and on brain oxidative stress caused by ischemia– reperfusion was examined. Results: It was found that 1 could protect rat liver from glutathione depletion, being comparable to Nacetylcysteine, the classical antidote against paracetamol overdose, and restore hepatic function, as judged by the levels of hepatic enzymes in plasma and the microscopic examination of multiple liver slices. After cerebral ischemia, 1 reduced caspase-3 by 60% and significantly decreased the number of apoptotic cells, especially in hippocampus and cerebellum.Export Options
About this article
Cite this article as:
Theodosis-Nobelos Panagiotis, Politou C. Theodora, Athanasekou Chrysoula and Rekka A. Eleni, Improved Anti-inflammatory Activity and Potential Cytoprotective Properties of Tolfenamic Acid, Naproxen and Indomethacin Derivatives, Letters in Drug Design & Discovery 2017; 14 (4) . https://dx.doi.org/10.2174/1570180813666160831143112
DOI https://dx.doi.org/10.2174/1570180813666160831143112 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Call for Papers in Thematic Issues
Navigating the Frontier: Probiotics' Promising Path in Combatting Viral Respiratory Infections, Spotlight on Coronaviridae.
Probiotics, well-known for their role in gut health, show promise in preventing and managing respiratory virus infections, particularly in children and at-risk populations. However, the profound influence of novel pathogenic viral RTIs such as coronaviruses has reshaped perspectives on the potential of probiotics. Despite their potential, significant gaps remain in ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapy Against Reperfusion-induced Microvascular Injury
Current Pharmaceutical Design Opioids: Old Drugs for Potential New Applications
Current Pharmaceutical Design The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury
Current Medicinal Chemistry Melatonin Receptor as a Drug Target for Neuroprotection
Current Molecular Pharmacology Glycaemic Control in Cardiac Surgery Patients: a Double-Edged Sword
Current Vascular Pharmacology Are Purinergic Receptors Overlooked Targets in Hyperinflammatory Responses?
Current Molecular Pharmacology Therapeutic Potential of Neuregulin in Cardiovascular System: Can we Ignore the Effects of Neuregulin on Electrophysiology?
Mini-Reviews in Medicinal Chemistry Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis
Current Pharmaceutical Biotechnology Phenolic Compounds as Antioxidants: Carbonic Anhydrase Isoenzymes Inhibitors
Mini-Reviews in Medicinal Chemistry Targeting Drugs to APJ Receptor: The Prospect of Treatment of Hypertension and Other Cardiovascular Diseases
Current Drug Targets Lipid-Induced Modulation of Protective Signalling Pathways in Cardiovascular Disease: The Role of High Density Lipoproteins
Current Signal Transduction Therapy Neuropeptide Receptors in Intestinal Disease: Physiology and Therapeutic Potential
Current Pharmaceutical Design Autophagy Inhibition Rescues Against Leptin-Induced Cardiac Contractile Dysfunction
Current Pharmaceutical Design Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology Strain and Strain Rate Imaging by Echocardiography - Basic Concepts and Clinical Applicability
Current Cardiology Reviews Exploitation of Some Natural Products for the Prevention and/or Nutritional Treatment of SARS-CoV2 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Microglial Cells on Neuroinflammation: Possible Therapeutic Applications
Recent Patents on Regenerative Medicine Estrogen Receptor Signaling: Impact on Cell Functions
Current Signal Transduction Therapy A Novel Botulinum Toxin TAT-EGFP-HCS Fusion Protein Capable of Specific Delivery Through the Blood-brain Barrier to the Central Nervous System
CNS & Neurological Disorders - Drug Targets Apoptosis and Acute Brain Ischemia in Ischemic Stroke
Current Vascular Pharmacology